Nanozymes for Treating Ocular Diseases
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202401309 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Ka-Ying Wong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Waterloo Institute for Nanotechnology, University of Waterloo, Waterloo, ON, N2L 3G1, Canada. Hauptthemen laut MEDLINE: Eye Diseases, Nanoparticles, Nanostructures. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Nanozymes, characterized by their nanoscale size and enzyme‐like catalytic activities, exhibit diverse therapeutic potentials, including anti‐oxidative, anti‐inflammatory, anti‐microbial, and anti‐angiogenic effects. These properties make them highly valuable in nanomedicine, particularly ocular therapy, bypassing the need for systemic delivery. Nanozymes show significant promise in tackling multi‐factored ocular diseases, particularly those influenced by oxidation and inflammation, like dry eye disease, and age‐related macular degeneration. Their small size, coupled with their ease of modification and integration into soft materials, facilitates the effective penetration of ocular barriers, thereby enabling targeted or prolonged therapy within the eye. This review is dedicated to exploring ocular diseases that are intricately linked to oxidation and inflammation, shedding light on the role of nanozymes in managing these conditions. Additionally, recent studies elucidating advanced applications of nanozymes in ocular therapeutics, along with their integration with soft materials for disease management, are discussed. Finally, this review outlines directions for future investigations aimed at bridging the gap between nanozyme research and clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Waterloo Institute for Nanotechnology, University of Waterloo, Waterloo, ON, N2L 3G1, Canada.
- Centre for Eye and Vision Research (CEVR), 17 W Hong Kong Science Park, Hong Kong.
- Department of Food Science and Nutrition, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong.
- Research Center for Chinese Medicine Innovation, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong.
ORCID-Profile: Juewen Liu
Zitieren
APA
Wong, K. Y., Wong, M. S., & Liu, J. (2025). Nanozymes for Treating Ocular Diseases. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401309
Vancouver
Wong KY, Wong MS, Liu J. Nanozymes for Treating Ocular Diseases. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202401309
BibTeX
@article{Wong2025,
author = {Wong, Ka-Ying and Wong, Man-Sau and Liu, Juewen},
title = {Nanozymes for Treating Ocular Diseases},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202401309}
}
EUVIMED